Viruses and Hodgkin lymphoma: No evidence of polyomavirus genomes in tumor biopsies

Leukemia and Lymphoma

Volumn 47, Issue 7, 2006, Pages 1315-1321

  Wilson, Katherine S ^a   Gallagher, Alice ^a   Freeland, June M L ^a   Shield, Lesley A ^a   Jarrett, Ruth F ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Degenerate PCR; Hodgkin lymphoma; Polyomavirus

Indexed keywords

CD30 ANTIGEN; DNA; TUMOR ANTIGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EPIDEMIOLOGICAL DATA; EPSTEIN BARR VIRUS; FEMALE; FLOW CYTOMETRY; GENETIC CODE; HODGKIN DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; LYMPH NODE BIOPSY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; POLYOMA VIRUS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; VIRUS GENOME; VIRUS STRAIN;

ADULT; AGED; BIOPSY; DNA PRIMERS; FEMALE; GENOME, VIRAL; HERPESVIRUS 4, HUMAN; HODGKIN DISEASE; HUMANS; LYMPH NODES; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; POLYOMAVIRUS;

EID: 33747662289     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190500525789     Document Type: Article

References (32)

1. Gutensohn, N and Cole, P. (1980) Epidemiology of Hodgkin's disease Seminars in Oncology, 7, pp. 92-102.
2. IARC. (1997) Proceedings of the IARC working group on the evaluation of carcinogenic risks to humans. In Epstein-Barr virus and Kaposi's sarcoma herpesvirus/human herpesvirus 8. Lyon: IARC. 17 - 24 June 1997
3. Jarrett, R. (2002) Viruses and Hodgkin's lymphoma Annals of Oncology, 13, pp. 23-29.
4. Jarrett, R and Krajewski, A and Angus, B and Freeland, J and Taylor, P and Taylor, G and Alexander, F. (2003) The Scotland and Newcastle epidemiological study of Hodgkin's disease: Impact of histopathological review and EBV status on incidence estimates Journal of Clinical Pathology, 56, pp. 811-816.
5. Gutensohn, N. (1982) Social class and age at diagnosis of Hodgkin's disease: New epidemiologic evidence for the 'two-disease hypothesis' Cancer Treatment Reports, 66, pp. 689-695.
6. Glaser, S. (1987) Regional variation in Hodgkin's disease incidence by histologic subtype in the US Cancer, 60, pp. 2841-2847.
7. Alexander, F and McKinney, P and Williams, J and Ricketts, T and Cartwright, R. (1991) Epidemiological evidence for the 'two-disease hypothesis' in Hodgkin's disease International Journal of Epidemiology, 20, pp. 354-361.
8. Gutensohn, N and Shapiro, D. (1982) Social class risk factors among children with Hodgkin's disease International Journal of Cancer, 30, pp. 433-435.
9. Paffenbarger, R, Jr and Wing, A and Hyde, R. (1977) Characteristics in youth indicative of adult-onset Hodgkin's disease Journal of the National Cancer Institute, 58, pp. 1489-1491.
10. Alexander, F and Jarrett, R and Lawrence, D and Armstrong, A and Freeland, J and Gokhale, D and (2000) Risk factors for Hodgkin's disease by Epstein-Barr virus (EBV) status: Prior infection by EBV and other agents British Journal of Cancer, 82, pp. 1117-1121.
11. Chang, E and Zheng, T and Weir, E and Borowitz, M and Mann, R and Spiegelman, D and Mueller, N. (2004) Childhood social environment and Hodgkin's lymphoma: New findings from a population-based case-control study Cancer Epidemiology; Biomarkers Prevention, 13, pp. 1361-1370.
12. Gallagher, A and Perry, J and Shield, L and Freeland, J and MacKenzie, J and Jarrett, R. (2002) Viruses and Hodgkin disease: No evidence of novel herpesviruses in non-EBV-associated lesions International Journal of Cancer, 101, pp. 259-264.
13. Cole, C and Conzen, S. (2001) Polyomaviridae: The viruses and their replication. In Fields virology 4th ed.. (pp. 2141-2174). Philadelphia: Lippincott Williams & Wilkins.
14. Shah, K and Nathanson, N. (1976) Human exposure to SV40: Review and comment American Journal of Epidemiology, 103, pp. 1-12.
15. Sangar, D and Pipkin, P and Wood, D and Minor, P. (1999) Examination of poliovirus vaccine preparations for SV40 sequences Biologicals, 27, pp. 1-10.
16. Vilchez, R and Madden, C and Kozinetz, C and Halvorson, S and White, Z and Jorgensen, J and (2002) Association between simian virus 40 and non-Hodgkin lymphoma Lancet, 359, pp. 817-823.
17. Shivapurkar, N and Harada, K and Reddy, J and Scheuermann, R and Xu, Y and McKenna, R and (2002) Presence of simian virus 40 DNA sequences in human lymphomas Lancet, 359, pp. 851-852.
18. MacKenzie, J and Wilson, K and Perry, J and Gallagher, A and Jarrett, R. (2003) Association between simian virus 40 DNA and lymphoma in the United Kingdom Journal of the National Cancer Institute, 95, pp. 1001-1003.
19. Brousset, P and De, A and Gascoyne, R. (2004) Immunohistochemical investigation of SV40 large T antigen in Hodgkin and non-Hodgkin's lymphoma International Journal of Cancer, 112, pp. 533-535.
20. Martini, F and Dolcetti, R and Gloghini, A and Iaccheri, L and Carbone, A and Boiocchi, M and Tognon, M. (1998) Simian-virus-40 footprints in human lymphoproliferative disorders of HIV- and HIV+ patients International Journal of Cancer, 78, pp. 669-674.
21. Nakatsuka, S and Liu, A and Dong, Z and Nomura, S and Takakuwa, T and Miyazato, H and Aozasa, K. (2003) Simian virus 40 sequences in malignant lymphomas in Japan Cancer Research, 63, pp. 7606-7608.
22. McNees, A and White, Z and Zanwar, P and Vilchez, R and Butel, J. (2005) Specific and quantitative detection of human polyomaviruses BKV, JCV, and SV40 by real time PCR Journal of Clinical Virology, 34, pp. 52-62.
23. Lopez-Rios, F and Illei, P and Rusch, V and Ladanyi, M. (2004) Evidence against a role for SV40 infection in human mesotheliomas and high risk of false-positive PCR results owing to presence of SV40 sequences in common laboratory plasmids Lancet, 364, pp. 1157-1166.
24. Volter, C and Hausen, H and Alber, D and de Villiers, E. (1997) Screening human tumor samples with a broad-spectrum polymerase chain reaction method for the detection of polyomaviruses Virology, 237, pp. 389-396.
25. Stein, H.(2001) Hodgkin lymphomas: Introduction. In World Health Organisation classification of tumours: Pathology and genetics of tumours of hematopoietic and lymphoid tissues. (pp. 238-239). Lyon: IARC.
26. Gallagher, A and Armstrong, A and MacKenzie, J and Shield, L and Khan, G and Lake, A and (1999) Detection of Epstein-Barr virus (EBV) genomes in the serum of patients with EBV-associated Hodgkin's disease International Journal of Cancer, 84, pp. 442-448.
27. Gluzman, Y. (1981) SV40-transformed simian cells support the replication of early SV40 mutants Cell, 23, pp. 175-182.
28. Saiki, R and Gelfand, D and Stoffel, S and Scharf, S and Higuchi, R and Horn, G and (1988) Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase Science, 239, pp. 487-491.
29. Gan, Y and Razzouk, B and Su, T and Sixbey, J. (2002) A defective, rearranged Epstein-Barr virus genome in EBER-negative and EBER-positive Hodgkin's disease American Journal of Pathology, 160, pp. 781-786.
30. Gallagher, A and Perry, J and Freeland, J and Alexander, F and Carman, W and Shield, L and (2003) Hodgkin lymphoma and Epstein-Barr virus (EBV): No evidence to support hit-and-run mechanism in cases classified as non-EBV-associated International Journal of Cancer, 104, pp. 624-630.
31. Staratschek-Jox, A and Kotkowski, S and Belge, G and Rudiger, T and Bullerdiek, J and Diehl, V and Wolf, J. (2000) Detection of Epstein-Barr virus in Hodgkin-Reed-Sternberg cells: No evidence for the persistence of integrated viral fragments inLatent membrane protein-1 (LMP-1)-negative classical Hodgkin's disease American Journal of Pathology, 156, pp. 209-216.
32. Knecht, H and Odermatt, B. (2003) Rearranged Epstein-Barr virus genome in Hodgkin's disease and angioimmunoblastic lymphadenopathy: Swiss results American Journal of Pathology, 163, pp. 369-370.